Showing results (241-250 of 617) with videos related to

Sort By:
Pageof 62
Annals of Hematology|November 6, 2019
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosisPhilipp Riffel, Mohamad Jawhar, Kristina Gawlik, et al.
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomasCecile Meier, Sylvia Hoeller, Caroline Bourgau, et al.
Blood|October 5, 2006
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosisNicolaus Kröger, Anita Badbaran, Ernst Holler, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension StudyGerald J Gleich, Florence Roufosse, Geoffrey Chupp, et al.
Blood|April 21, 2010
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasmsStephen T Oh, Erin F Simonds, Carol Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosisJeffrey W Craig, Robert P Hasserjian, Annette S Kim, et al.
Leukemia & Lymphoma|February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Cancer|January 31, 2018
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATEElias J Jabbour, Daniel J DeAngelo, Matthias Stelljes, et al.
Pageof 62